New Iridium(III) complex with application as photo-catalyst and for the cancer treatment
Researchers from a Spanish university have patented a synthetic process of cationic Iridium(III) complexes with characteristics that differentiate them from the known complexes (activity as photocatalysts or photosensitizers), so can be used as drug, particularly interesting for antitumor use in photodynamic therapy. They expect to collaborate with chemical or pharmaceutical industry and R&D institutions under license agreement, manufacturing agreement and/or research cooperation agreement.